Authors:
Haioun, C
Besson, C
Lepage, E
Thieblemont, C
Simon, D
Rose, C
Tilly, H
Sonet, A
Lederlin, P
Attal, M
Briere, J
Reyes, F
Citation: C. Haioun et al., Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients, ANN ONCOL, 11(6), 2000, pp. 685-690
Authors:
Van den Neste, E
Louviaux, I
Michaux, JL
Delannoy, A
Michaux, L
Sonet, A
Bosly, A
Doyen, C
Mineur, P
Andre, M
Straetmans, N
Coche, E
Venet, C
Duprez, T
Ferrant, A
Citation: E. Van Den Neste et al., Phase I/II study of 2-chloro-2 '-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent. non-Hodgkin's lymphoma, LEUKEMIA, 14(6), 2000, pp. 1136-1142
Authors:
Ketterer, N
Sonet, A
Dumontet, C
Moullet, I
Thieblemont, C
Espinouse, D
Bouafia, F
Coiffier, B
Salles, G
Citation: N. Ketterer et al., Toxicities after peripheral blood progenitor cell transplantation for lymphoid malignancies: analysis of 300 cases in a single institution, BONE MAR TR, 23(12), 1999, pp. 1309-1315